VIR vs. CRT

In the year-to-date period, VIR achieves a -36.78% return, which is significantly lower than CRT's 8.25% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Vir Biotechnology, Inc. (VIR) and Cross Timbers Royalty Trust (CRT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current VIR Sharpe Ratio is -0.59, which is comparable to the CRT Sharpe Ratio of -0.48. The chart below compares the historical Sharpe Ratios of VIR and CRT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

VIR has not paid dividends to shareholders, while CRT's dividend yield for the trailing twelve months is around 8.56%.

The maximum VIR drawdown since its inception was -94.58%, which is greater than CRT's maximum drawdown of -83.46%. Use the drawdown chart below to compare losses from any high point for VIR and CRT. For additional features, visit the drawdowns tool.

Vir Biotechnology, Inc. (VIR) has a higher volatility of 19.69% compared to Cross Timbers Royalty Trust (CRT) at 6.48%. This indicates that VIR's price experiences larger fluctuations and is considered to be riskier than CRT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Vir Biotechnology, Inc. and Cross Timbers Royalty Trust. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.